During the follow-up period, significant weight regain was observed from 8 to 52 weeks after treatment discontinuation (Figs
[1] Important safety considerations include the risk of hypoglycaemia when combined with insulin or sulfonylureas, potential dehydration and acute kidney injury with severe gastrointestinal symptoms, and for semaglutide specifically, possible worsening of diabetic retinopathy in those with pre-existing disease
Metabolic/bariatric surgery in the past 5 years was found in 5.4% of patients
For patients with BMI 30 or 27 with comorbidities, FDA-approved pharmacotherapy may be appropriate alongside lifestyle modification
Glucagon-Like Peptide-1 Receptor Agonist Liraglutide Ameliorates the Development of Periodontitis. Journal of Diabetes Research , edited by Yoshifumi Saisho, vol
A wrongful death lawsuit filed in federal court in Washington alleges Amazon failed to act despite repeated purchases of flavored nitrous oxide canisters and inhalation accessories by a Georgia woman who later suffered severe neurological injuries and died during rehabilitation
